- Report
- March 2025
- 1048 Pages
Global
From €4266EUR$4,799USD£3,702GBP
- Report
- May 2022
- 32 Pages
Global
From €400EUR$482USD£359GBP
- Report
- December 2024
- 581 Pages
Global
From €4400EUR$4,950USD£3,819GBP
- Report
- July 2024
- 335 Pages
Global
From €4400EUR$4,950USD£3,819GBP
From €600EUR$723USD£539GBP
From €600EUR$723USD£539GBP
From €600EUR$723USD£539GBP
From €450EUR$542USD£404GBP
From €450EUR$542USD£404GBP
From €450EUR$542USD£404GBP
From €450EUR$542USD£404GBP
From €450EUR$542USD£404GBP
From €300EUR$362USD£269GBP
From €300EUR$362USD£269GBP
From €300EUR$362USD£269GBP
From €200EUR$241USD£180GBP
- Report
- August 2023
- 267 Pages
Global
From €2150EUR$2,591USD£1,931GBP
- Report
- July 2021
- 259 Pages
Global
From €2150EUR$2,591USD£1,931GBP
- Report
- July 2022
- 263 Pages
Global
From €1800EUR$2,169USD£1,617GBP
- Report
- April 2025
- 240 Pages
Global
From €2133EUR$2,400USD£1,851GBP

Immunotherapy is a type of treatment used to treat immune disorders, such as allergies, asthma, and autoimmune diseases. It works by stimulating the body's own immune system to fight off disease-causing agents. Immunotherapy drugs are designed to target specific parts of the immune system, such as T-cells, B-cells, and cytokines. These drugs can be used to treat a variety of conditions, including cancer, HIV/AIDS, and rheumatoid arthritis.
Immunotherapy drugs are typically administered through injections, infusions, or oral medications. They can also be used in combination with other treatments, such as chemotherapy or radiation therapy. The goal of immunotherapy is to reduce the severity of symptoms and improve the patient's quality of life.
The immunotherapy market is a rapidly growing sector of the pharmaceutical industry. Companies in this market are focused on developing new treatments and therapies to treat immune disorders. Some of the major players in this market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, and Pfizer. Show Less Read more